ArticleJournal of hematology & oncology2023

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

Miranda H Meeuwsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.